Many of us, who are dealing with advanced prostate cancer, become understandably concerned about our rising PSA. Given free choice, we all would be much happier if our PSA just disappeared and became undetectable. Granted, a rising PSA is indeed a bad sign, but the rate of rise and how we actually feel is more [...]
The last few days have seen a lot of commotion and celebrating in the prostate cancer world. There have been multiple news stories of an experimental prostate cancer drug, abiraterone, that has been reported to dramatically shrink prostate cancer tumors and extend survival in 70 to 80 percent of men with aggressive prostate cancer. Abiraterone [...]
Ketoconazole (kee-ta-KOE-na-zol), generic name for Nizoral, is an oral drug approved by the FDA for the use to treat fungal infections. However, it has been shown that higher doses of ketoconazole (800-1200mg/day vs 200-400mg/day) also block the production of both free and bound testosterone. Since high-dose Ketoconazole (HDK) has testosterone lowering effects, operating both on [...]
Oh no, another not so very clear issue for men with prostate cancer has emerged! According to an article written by Tara Parker-Pope in the New York Times, bisphosphonates (i.e. Fosamax), has been reported, in some rare occasions, to actually cause weaker bones that lead to an unusual type of fracture of the femur. Bisphosphonates [...]
Yesterday afternoon Senators Harkin and Specter introduced a landmark supplemental funding bill for the NIH. The Senator's bill proposes providing the National Cancer Institute with an additional $1.2 billion and the rest of the National Institutes of Health with $4 billion for FY 2008. This bill stems from their concern about the inadequate funding for [...]